Clincosm LogoSign in Get a demo

melanoma

Showing NaN - NaN of 147
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma, Renal Cell Carcinoma, NSCLC Trial in United States (HBI-8000 in combination with nivolumab)

Active, not recruiting
  • Melanoma
  • +2 more
  • HBI-8000 in combination with nivolumab
  • Phoenix, Arizona
  • +5 more
Jun 11, 2022

Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial in United States (DCC-3116, Trametinib, Binimetinib)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +5 more
  • Boston, Massachusetts
  • +4 more
May 25, 2022

Cancer, Melanoma Trial in Worldwide (drug, biological, other)

Recruiting
  • Cancer
  • Melanoma
  • Springdale, Arkansas
  • +70 more
May 16, 2022

Liver Malignant Tumors, Cholangiocarcinoma Metastatic, Pancreatic Cancer Trial in Houston (high dose rate brachytherapy)

Recruiting
  • Liver Malignant Tumors
  • +3 more
  • high dose rate brachytherapy
  • Houston, Texas
    M D Anderson Cancer Center
Apr 25, 2022

Thyroid, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (SO-C101, pembrolizumab)

Recruiting
  • Thyroid
  • +18 more
  • New Haven, Connecticut
  • +6 more
Apr 8, 2022

NSCLC, Small Cell Lung Cancer, Urothelial Carcinoma Trial in United States (N-803 + Pembrolizumab, N-803 + Nivolumab, N-803 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • N-803 + Pembrolizumab
  • +9 more
  • Anchorage, Alaska
  • +34 more
Apr 4, 2022

Melanoma Trial in Worldwide (Relatlimab, Nivolumab)

Active, not recruiting
Has Results
  • Melanoma
  • Relatlimab
  • Nivolumab
  • Tucson, Arizona
  • +126 more
Mar 2, 2022

Melanoma Trial in Australia, United States (PV-10, Pembrolizumab)

Recruiting
  • Melanoma
  • Los Angeles, California
  • +6 more
Mar 22, 2022

Melanoma, Carcinoma, Non-Small- Cell Lung Trial in Worldwide (SEA-CD40, pembrolizumab, pemetrexed)

Recruiting
  • Melanoma
  • Carcinoma, Non-Small- Cell Lung
  • Springdale, Arkansas
  • +18 more
Mar 11, 2022

Melanoma Trial in France, Germany, United States (Talimogene laherparepvec, Ipilimumab)

Completed
Has Results
  • Melanoma
  • Tucson, Arizona
  • +39 more
Mar 9, 2022

Advanced Cancers, Melanoma Trial in Houston (MGN1703, Ipilimumab)

Active, not recruiting
  • Advanced Cancers
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 11, 2022

Melanoma, Non Small Cell Lung Cancer Trial in United States (enoblituzumab plus ipilimumab)

Completed
  • Melanoma
  • Non Small Cell Lung Cancer
  • enoblituzumab plus ipilimumab
  • Los Angeles, California
  • +9 more
Feb 4, 2022

Melanoma Trial in Houston (ABI-007, Ipilimumab, Phone Call)

Completed
Has Results
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 12, 2022

Squamous Cell Carcinoma of the Head and Neck, Melanoma, Non Small Cell Lung Cancer Trial in Worldwide (SL-279252)

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • +12 more
  • Nashville, Tennessee
  • +4 more
Feb 3, 2022

Melanoma Trial in Houston (LL37, Photographs)

Completed
Has Results
  • Melanoma
  • LL37
  • Photographs
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 7, 2021

Melanoma Trial in Canada, United States (POL-103A, POL-103A without API)

Terminated
  • Melanoma
  • POL-103A
  • POL-103A without API
  • Chandler, Arizona
  • +64 more
Dec 6, 2021

Long-term, Non-interventional, Observational Study Following

Recruiting
  • Advanced Solid Tumor
  • +17 more
  • Allogeneic natural killer (NK) cell
  • San Diego, California
  • +3 more
Oct 15, 2021

Melanoma Trial in United States (Ipilimumab, Nivolumab)

Completed
Has Results
  • Melanoma
  • Duarte, California
  • +35 more
Sep 8, 2021

Melanoma Trial in Worldwide (nivolumab, ipilimumab)

Completed
Has Results
  • Melanoma
  • nivolumab
  • ipilimumab
  • Tucson, Arizona
  • +123 more
Aug 24, 2021

Clear Cell Renal Cell Carcinoma (ccRCC), Melanoma, NSCLC (NSCLC) Trial in United States (CB-839, Nivolumab)

Completed
  • Clear Cell Renal Cell Carcinoma (ccRCC)
  • +2 more
  • Scottsdale, Arizona
  • +16 more
Aug 16, 2021

Melanoma Trial in Houston (gp100, R848 gel, MAGE-3)

Completed
Has Results
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 20, 2021

Triple Negative Breast Cancer, Pancreatic Carcinoma, Melanoma Trial in Worldwide (MCS110, PDR001)

Completed
Has Results
  • Triple Negative Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +19 more
Jul 12, 2021

Melanoma, Unresectable (Stage III) Melanoma, Metastatic (Stage IV) Melanoma Trial in United States (Omaveloxolone Capsules (2.5

Completed
Has Results
  • Melanoma
  • +2 more
  • Omaveloxolone Capsules (2.5 mg/capsule)
  • +4 more
  • Mobile, Alabama
  • +9 more
Jun 4, 2021

Melanoma Trial in Worldwide (Nivolumab, Ipilimumab)

Withdrawn
  • Melanoma
  • Nivolumab
  • Ipilimumab
  • Gilbert, Arizona
  • +117 more
Mar 17, 2021

Melanoma Trial in Louisville, Pittsburgh, Houston (TKI258)

Completed
  • Melanoma
  • Louisville, Kentucky
  • +2 more
Mar 9, 2021